Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
Operating Income
Vivos Therapeutics Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Operating Income
-$17.3m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Operating Income
$1.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Operating Income
$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
CVS Health Corp
NYSE:CVS
|
Operating Income
$15.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Cigna Corp
NYSE:CI
|
Operating Income
$9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Operating Income
$1.1B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
2%
|
See Also
What is Vivos Therapeutics Inc's Operating Income?
Operating Income
-17.3m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Operating Income amounts to -17.3m USD.
What is Vivos Therapeutics Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-16%
Over the last year, the Operating Income growth was 31%. The average annual Operating Income growth rates for Vivos Therapeutics Inc have been -13% over the past three years , -16% over the past five years .